What does CUSIP 04335A105 represent in this 13F holders report?

CUSIP 04335A105 is the security identifier for ARVN - Arvinas, Inc. - Common stock, par value $0.001 per share used to aggregate holder disclosures.

How many institutions held ARVN - Arvinas, Inc. - Common stock, par value $0.001 per share in Q3 2019?

81 institutional investors reported ARVN - Arvinas, Inc. - Common stock, par value $0.001 per share for Q3 2019. Use the holders table for investor-level position and value details.

Arvinas, Inc. - Common stock, par value $0.001 per share (ARVN)

CUSIP: 04335A105

Q3 2019 13F Holders as of 30 Sep 2019

Security type / class: Equity / Common stock, par value $0.001 per share
Total 13F shares: 16,126,090
Total 13F value: $347,535,434
Share change: +828,551
SEC-reported price per share: $21.55
Number of holders: 81
Value change: +$17,714,443
Number of buys: 51
Number of sells: 20
Shares outstanding: 64,725,056

Security key

04335A105

Report period

Q3 2019

Institutions

Top holders

ARVN full security history Ownership snapshot Full 13F holder table ARVINAS, INC. SEC filings ARVINAS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ARVN - Arvinas, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ORBIMED ADVISORS LLC

Disclosed value leader

ORBIMED ADVISORS LLC

Comparable rows

15/15

Latest evidence

30 Jun 2019

13F Lead comparable stake: 4.1% Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 4.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.

Comparable ownership Top 5

ORBIMED ADVISORS LLC 4.1%

New Leaf Venture Partners, L.L.C. 3.5%

RA CAPITAL MANAGEMENT, L.P. 2.6%

BlackRock Finance, Inc. 1.6%

DEERFIELD MANAGEMENT COMPANY, L.P. 1.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ORBIMED ADVISORS LLC	13F Company 13F	4.1%	$58,907,000 2,678,810 shares	—	30 Jun 2019
New Leaf Venture Partners, L.L.C.	13F Company 13F	3.5%	$50,204,000 2,283,048 shares	—	30 Jun 2019
RA CAPITAL MANAGEMENT, L.P.	13F Company 13F	2.6%	$37,128,000 1,688,412 shares	—	30 Jun 2019
BlackRock Finance, Inc.	13F Company 13F	1.6%	$22,845,000 1,038,838 shares	—	30 Jun 2019
DEERFIELD MANAGEMENT COMPANY, L.P.	13F Company 13F	1.4%	$20,258,000 921,234 shares	—	30 Jun 2019
RTW INVESTMENTS, LP	13F Company 13F	1.2%	$17,765,000 807,870 shares	—	30 Jun 2019

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

16,126,090

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2019 vs Q2 2019 Across Filers

Q2 2019 holders

Q3 2019 holders

Holder diff

Investor	Q2 2019 Shares	Q3 2019 Shares	Share Diff	Share Chg %	Q2 2019 value	Q3 2019 value	Value change	Value Chg %